Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...

Read on to learn everything we know about Fallout 5. If you've ever played a Fallout game, you'll know the series revels in its nuclear-ravaged American setting. Fallout games have all been set in ...

Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the next Chief Executive Officer (“CEO ...

Masimo (Nasdaq: MASI) + announced today that it appointed Katie Szyman as its new CEO, effective Feb. 12, 2025. Szyman’s appointment comes after a topsy-turvy year for the home health monitoring ...

October 22, 2024--Masimo (NASDAQ: MASI) will release third quarter 2024 financial results for the period ended September 28, 2024, after the market closes on Tuesday, November 5, 2024. The ...

Looking ahead, for the full-year 2025, excluding items, Masimo expects income per share of $4.90 to $5.10, with adjusted operating profit of $398 million to $406 million, representing adjusted ...

For 2025, Masimo forecast healthcare revenue between $1.5 billion and $1.53 billion as well as adjusted earnings per-share in the range of $4.90 and $5.10. Write to Denny Jacob at denny.jacob@wsj ...

Sees FY25 operating margins at least 26.5%. Published first on TheFly – the ... performing stocks on TipRanks >> Read More on MASI: Masimo CorpShs NewsMORE Related Stocks Indices Commodities ...

Full-Year 2025 Guidance incorporates the financial impact of one additional calendar week for the healthcare business, which occurs every five or six years based on Masimo’s 4-4-5 fiscal ...

Masimo (Nasdaq: MASI) + today announced preliminary financial results for the fourth quarter of 2024 and for the full year. MASI shares fell 2.5% to $167.73 apiece this morning. In spite of the ...